Trials / Completed
CompletedNCT03555617
Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
A Phase 1, Open-Label, 2-Cohort Study to Assess the Single Dose Pharmacokinetics of Two Formulations of TD-1473 and to Assess the Effect of a High-Fat Meal and Itraconazole on the Pharmacokinetics of TD-1473 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Theravance Biopharma · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 1, open-label, 2-cohort, food-effect, DDI, and formulation bridging study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TD-1473 | oral capsule/tablet, QD |
| DRUG | Itraconazole | oral solution, QD |
Timeline
- Start date
- 2018-06-13
- Primary completion
- 2018-07-15
- Completion
- 2018-07-15
- First posted
- 2018-06-13
- Last updated
- 2021-01-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03555617. Inclusion in this directory is not an endorsement.